首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿卡波糖与混合胰岛素联合应用的临床意义
引用本文:黄昭碹,黄昭穗,李燕娃,尹秀英.阿卡波糖与混合胰岛素联合应用的临床意义[J].临床军医杂志,2008,36(3).
作者姓名:黄昭碹  黄昭穗  李燕娃  尹秀英
作者单位:解放军第174医院,内分泌科,福建,厦门,361003
摘    要:目的观察混合重组人胰岛素(诺和灵30R)与午餐加服阿卡波糖对午餐后2 h血糖及对糖化血红蛋白的影响。方法54例2型糖尿病人,随机分为对照组(单纯采用混合重组人胰岛素治疗)和治疗组(采用混合重组人胰岛素治疗)与午餐加服阿卡波糖治疗,查分组时及8周后的空腹血糖、三餐后血糖、糖化血红蛋白及血脂,进行统计学处理。结果8周时,治疗组的午餐及晚餐后血糖和糖化血红蛋白较对照组明显下降(P<0.05),血脂两组无明显变化(P>0.05)。结论午餐加服阿卡波糖,可改善诺和灵30R对午餐后血糖控制不良的缺陷。

关 键 词:诺和灵30R  阿卡波糖  2型糖尿病

Combination Therapy with Acorbose and Mixed Insulin
Huang Zhao-xuan,Huang Zhao-sui,Li Yan-wa,Yin Xiu-ying.Combination Therapy with Acorbose and Mixed Insulin[J].Clinical Journal of Medical Officer,2008,36(3).
Authors:Huang Zhao-xuan  Huang Zhao-sui  Li Yan-wa  Yin Xiu-ying
Institution:Huang Zhao-xuan,Huang Zhao-sui,Li Yan-wa,Yin Xiu-ying(Department of Endocrinology,PLA No.174 Hospital,Xiamen 361003,China)
Abstract:Objective To compare the efficacy of treatment between mixed insulin(Nov30R) alone and Nov30R plus acarbose at noon in the patients with type 2 diabetes who showed postprandial hyperglycemia.Methods A total of 54 subjects with type 2 diabetes were divided into acarbose-treated group(n=27) treated with Nov30R plus acarbose at noon for eight weeks and control group(n=27) treated with Nov30R alone,at random.Results Compared with that of the control group,the levels of post-lunch and post-supper glucose of the ...
Keywords:mixed insulin  acarbose  diabetes  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号